Fragment‐Based De Novo Design Reveals a Small‐Molecule Inhibitor of Helicobacter Pylori HtrA
Authors:
- Thomas P. SchmidtTSThomas P. Schmidt
- Manja BöhmMBManja Böhm
- Steffen BackertSBSteffen Backert
- Silja WesslerSWSilja Wessler
- Gisbert SchneiderGSGisbert Schneider
- 9 June 2015
- journal article
- zuschrift
- Published by Wiley in Angewandte Chemie
- Vol. 127 (35) , 10382-10386
Abstract
Sustained identification of innovative chemical entities is key for the success of chemical biology and drug discovery. We report the fragment‐based, computer‐assisted de novo design of a small molecule inhibiting Helicobacter pylori HtrA protease. Molecular binding of the designed compound to HtrA was confirmed through biophysical methods, supporting its functional activity in vitro. Hit expansion led to the identification of the currently best‐in‐class HtrA inhibitor. The results obtained reinforce the validity of ligand‐based de novo design and binding‐kinetics‐guided optimization for the efficient discovery of pioneering lead structures and prototyping drug‐like chemical probes with tailored bioactivity.Keywords
Funding Information
- OPO Foundation, Zurich
- Austrian Science Fund (FWF)
This publication has 30 references indexed in Scilit:
- Steering Target Selectivity and Potency by Fragment‐Based De Novo Drug DesignAngewandte Chemie International Edition, 2013
- Steering Target Selectivity and Potency by Fragment‐Based De Novo Drug DesignAngewandte Chemie, 2013
- De novo design and optimization of Aurora A kinase inhibitorsChemical Science, 2013
- Drugs by Numbers: Reaction‐Driven De Novo Design of Potent and Selective Anticancer LeadsAngewandte Chemie International Edition, 2012
- Wirkstoffe nach Zahlen: reaktionsbasierter De-novo-Entwurf von potenten und selektiven Leitstrukturen für die KrebsforschungAngewandte Chemie, 2012
- Distinct Roles of Secreted HtrA Proteases from Gram-negative Pathogens in Cleaving the Junctional Protein and Tumor Suppressor E-cadherinJournal of Biological Chemistry, 2012
- The structural basis of mode of activation and functional diversity: A case study with HtrA family of serine proteasesArchives of Biochemistry and Biophysics, 2011
- Drug discovery in the next decade: innovation needed ASAPDrug Discovery Today, 2011
- Helicobacter pyloriand Gastric Cancer: Factors That Modulate Disease RiskClinical Microbiology Reviews, 2010
- Host-Bacterial Interactions in Helicobacter pylori InfectionGastroenterology, 2008